JENNIFER HRIVNAK: Open Payments
NPI 1740531086 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 40 payments from 10 companies in 2025. Trend: 2023 $993 · 2024 $1,096 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $219 |
| Corcept Therapeutics | 7 | $172 |
| ABBVIE INC. | 15 | $161 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| PFIZER INC. | 2 | $43 |
| Amgen Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, Korlym, UBRELVY, QULIPTA, SHINGRIX, PREVNAR 20, BREZTRI, OTEZLA.
Industry payments across WA — which companies pay providers there.
